Severe Eczema Drug Is Approved by F.D.A.; Price Tag Is $37,000 a Year by KATIE THOMAS


By KATIE THOMAS

The drug makers Regeneron Pharmaceuticals and Sanofi made a rare move, negotiating with insurers in advance over the price for Dupixent.

Published: March 27, 2017 at 08:00PM

from NYT Health http://ift.tt/2nIKI6n
via IFTTT

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s